Allobarbital | |
---|---|
Molecular structure via molpic based on CDK |
Physical properties [] | |
---|---|
Molecular mass | 208.21 g/mol [1] |
Predicted LogP | 1 [1] |
Structural Identifiers [] | |
---|---|
Molecular formula | C10H12N2O3 [1] |
IUPAC name | 5,5-bis(prop-2-enyl)-1,3-diazinane-2,4,6-trione [1] |
SMILES | C=CCC1(C(=O)NC(=O)NC1=O)CC=C [1] |
InChI | InChI=1S/C10H12N2O3/c1-3-5-10(6-4-2)7(13)11-9(15)12-8(10)14/h3-4H,1-2,5-6H2,(H2,11,12,13,14,15) [1] |
InChIKey | FDQGNLOWMMVRQL-UHFFFAOYSA-N [1] |
Allobarbital
Allobarbital (also known as 5,5-Diallylbarbituric acid, Allobarbitone, Diallylbarbital, Diallymal, Alobarbital, Diallylbarbituric acid, Allobarbitalum, 2,4,6(1H,3H,5H)-Pyrimidinetrione, 5,5-di-2-propenyl-, diallylmal or diallyl barbituric acid) is a
Chemistry
Stereochemistry []
Allobarbital is a achiral mixture
Legal status
- Brazil: Allobarbital is a B1 substance.[3]
- Canada: Allobarbital is a Schedule IV substance.
- United States: Allobarbital is a Schedule I under the "Controlled Substances Act (CSA)".
- Germany: Allobarbital is a Anlage III substance.
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 5842, Allobarbital. Accessed July 13, 2025. https://pubchem.ncbi.nlm.nih.gov/compound/5842
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Allobarbital. UNII: 8NT43GG2HA. Global Substance Registration System. Accessed July 13, 2025. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/8NT43GG2HA
Anvisa. RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. March 31, 2023. Accessed July 13, 2025. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992